The previous studies [24,25] suggest that FTO might contribute to tumor growth; hence, we performed gene and protein expression analysis on NSCLC cell lines to examine whether FTO is upregulated in EGFR-TKI-resistant cell lines. The gene discussed is FTO; the disease is non-small cell lung carcinoma.